Scientists launch 5-year watch on rare genetic Parkinson's to unlock disease secrets
NCT ID NCT07613112
First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 3 times
Summary
This study follows 70 people with PRKN- or PINK1-linked Parkinson's disease, as well as those with typical Parkinson's and healthy volunteers, over 5 years. Researchers will track movement, thinking, and mood symptoms, and collect blood, urine, and optional spinal fluid or muscle samples. The goal is to better understand how these genetic forms of Parkinson's progress, which could help design future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how genetic forms of Parkinson's progress, pointing toward better monitoring or future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead directly to new therapies, and results may take years to apply.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.